D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ACRS holding history
Aclaris Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ACRS overviewAll 13F holders of ACRSFull Q2 2026 holdings
- Shares (Q2 2026)
- 414,499
- Value
- $2.19M
- % of portfolio
- <0.1%
- Quarters held
- 16
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 414,499 | $2.19M | <0.1% | −486,305−54.0% | Reduced | Holders |
| Q1 2026 | 900,804 | $3.38M | <0.1% | −1,195,847−57.0% | Reduced | Holders |
| Q4 2025 | 2,096,651 | $6.31M | <0.1% | −276,575−11.7% | Reduced | Holders |
| Q3 2025 | 2,373,226 | $4.51M | <0.1% | −427,056−15.3% | Reduced | Holders |
| Q2 2025 | 2,800,282 | $3.98M | <0.1% | −144,230−4.9% | Reduced | Holders |
| Q1 2025 | 2,944,512 | $4.51M | <0.1% | −349,113−10.6% | Reduced | Holders |
| Q4 2024 | 3,293,625 | $8.17M | <0.1% | −78,224−2.3% | Reduced | Holders |
| Q3 2024 | 3,371,849 | $3.88M | <0.1% | +51,643+1.6% | Added | Holders |
| Q2 2024 | 3,320,206 | $3.65M | <0.1% | +37,224+1.1% | Added | Holders |
| Q1 2024 | 3,282,982 | $4.07M | <0.1% | +1,343,972+69.3% | Added | Holders |
| Q4 2023 | 1,939,010 | $2.04M | <0.1% | +1,873,000+2,837.4% | Added | Holders |
| Q3 2023 | 66,010 | $452.2K | <0.1% | +37,087+128.2% | Added | Holders |
| Q2 2023 | 28,923 | $299.9K | <0.1% | +28,923 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −22,864−100.0% | Sold out | Holders |
| Q4 2021 | 22,864 | $332.0K | <0.1% | −40,758−64.1% | Reduced | Holders |
| Q3 2021 | 63,622 | $1.15M | <0.1% | −205,633−76.4% | Reduced | Holders |
| Q2 2021 | 269,255 | $4.73M | <0.1% | +269,255 | New | Holders |